Cambrex | Sustainability Performance
Offers contract development and manufacturing services for small molecule therapeutics, providing active pharmaceutical ingredients and finished dosage forms.
1981
United States
1,001 - 5,000 employees
Pharmaceuticals
$500M - 1B in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#8709
Overall#1983
in United States#208
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Controversy level
- Cambrex's pharmaceutical contract manufacturing operations face FDA Form 483 observations and quality compliance scrutiny at multiple US and European facilities affecting client production schedules.
